Company news

Intelligent Bio Solutions Inc. news in 2026

Intelligent Bio Solutions Inc.'s news releases, calls and decks from 2026, newest first.

View company

Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12

November 4, 2026

Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4: 30 p.m. ET

September 10, 2026

Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance

September 9, 2026

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

September 1, 2026

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules

September 1, 2026

Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification

August 17, 2026

Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

August 11, 2026

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

August 5, 2026

Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System

August 3, 2026

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry

July 23, 2026

Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market

July 21, 2026

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

June 16, 2026

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

June 3, 2026

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

June 1, 2026

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

May 13, 2026

Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results

April 20, 2026

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

April 17, 2026

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

April 1, 2026

Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant

March 25, 2026

Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry

February 25, 2026

Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout

February 24, 2026

Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year

February 12, 2026

Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year

February 5, 2026

Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market

January 28, 2026

Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

January 2, 2026

Decks in 2026